grant PAR-24-279

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

This funding opportunity supports short-term clinical trials that explore a wide variety of research questions. Trials can involve drugs, biologics, devices, or therapies related to surgery, diet, behavior, or rehabilitation, as long as they align with the NIAMS mission and goals.

The goal of the NIAMS clinical trial program is to support research leading to the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. The purpose of the Exploratory Clinical Trials Grants Program is t…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards & funding

Award Ceiling: $600,000

Eligibility

U.S. Territory or Possession
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Regional Organizations
Higher Education Institutions - Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education - without 501(c)(3) IRS Status
For-Profit Organizations (Other than Small Businesses)
Federal Government - Eligible Agencies of the Federal Government
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations

Foreign/Non-domestic entities are NOT eligible to apply: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are also not eligible. However, foreign components (as defined in the NIH Grants Policy Statement)…

Dates

Opportunity Released: December 9, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.